LakeShore Biopharma Co., Ltd (LSBCF)
OTCMKTS · Delayed Price · Currency is USD
0.0443
0.00 (0.00%)
Mar 17, 2026, 4:00 PM EST
LakeShore Biopharma Market Cap
LakeShore Biopharma has a market cap or net worth of $1.82 million as of March 19, 2026. Its market cap has decreased by -95.98% in one year.
Market Cap
1.82M
Enterprise Value
55.06M
Revenue
84.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since August 5, 2021, LakeShore Biopharma's market cap has decreased from 227.76M to 1.82M, a decrease of -99.20%. That is a compound annual growth rate of -64.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 16, 2026 | 1.82M | -94.73% |
| Dec 31, 2025 | 34.62M | -47.56% |
| Dec 31, 2024 | 66.02M | 38.83% |
| Dec 29, 2023 | 47.55M | -80.26% |
| Dec 30, 2022 | 240.85M | 3.14% |
| Dec 29, 2021 | 233.52M | 2.53% |
| Aug 5, 2021 | 227.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Clearside Biomedical | 2.88M |
| ProtoKinetix | 2.78M |
| AXIM Biotechnologies | 2.59M |
| VitaSpring Biomedical | 2.30M |
| Sorrento Therapeutics | 2.07M |
| Agentix | 1.94M |
| ZyVersa Therapeutics | 1.94M |
| Vaccinex | 1.87M |